Ectopic Pregnancy Clinical Trial
Official title:
Can Kisspeptin be Used for Differential Diagnosis of Early Pregnancies?
Kisspeptins are a family of neuropeptides that are critical for the puberty initiation and female fertility. The investigators aimed to investigate in this study kisspeptin levels in early pregnancy, ectopic pregnancy, and early pregnancy loss.
Clinicians can easily do a differential diagnosis of early pregnancy, miscarriage, and
ectopic pregnancy when the human chorionic gonadotropin (hCG) values higher than 2000 mIU/mL
with transvaginal ultrasound. However, in cases where the hCG value is below the critical
threshold of 1500 to 2000 mIU/mL (often called the discrimination level) and ultrasound is
not likely to be diagnostic, the pregnancy is of unknown location. Plasma or serum kisspeptin
is mainly derived from the placenta during pregnancy and plasma kisspeptin levels
significantly increase across pregnancy. Plasma kisspeptin levels could be used as a
potential biomarker for the discrimination of miscarriage and ectopic pregnancy.
All statistics will be carried out with the use of SPSS (ver. 21, IBM). A P value of <.05 is
considered to be statistically significant. Pearson chi-square test will be used to evaluate
between-group differences by pregnancy outcome for categoric data. Kisspeptin differences
will be calculated between groups with one way ANOVA.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02995356 -
Evaluation of the Axonemal Dynein Heavy Chain 5 and Creatine Kinase Concentration in Cervical Fluid for Early Detection of the Ectopic Pregnancy
|
||
Completed |
NCT01876004 -
Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy
|
Phase 4 | |
Not yet recruiting |
NCT05039853 -
Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task
|
N/A | |
Completed |
NCT00194207 -
Risk Factors of Ectopic Pregnancy
|
N/A | |
Completed |
NCT00827970 -
Randomized Population-Based Study on Chlamydia Trachomatis Screening
|
N/A | |
Recruiting |
NCT05374720 -
Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy
|
N/A | |
Completed |
NCT03894735 -
Vitamin D in Ectopic Pregnancies
|
||
Recruiting |
NCT01860690 -
BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success
|
Phase 4 | |
Recruiting |
NCT04176549 -
Assessment of Biomarkers in Ectopic Pregnancy
|
||
Not yet recruiting |
NCT05890066 -
Single-port Versus Multi-port Laparoscopic Surgery for Ectopic Pregnancy
|
N/A | |
Completed |
NCT01855568 -
Methotrexate Treatment for Ectopic Pregnancy
|
Phase 3 | |
Not yet recruiting |
NCT04308343 -
The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
|
N/A | |
Recruiting |
NCT06354439 -
Use of Letrozole for Ectopic Pregnancy
|
Phase 4 | |
Not yet recruiting |
NCT06300333 -
Treatment of Ectopic Pregnancy by Low Dose of Methotrexate
|
||
Completed |
NCT00194272 -
Two-Dose Methotrexate for Ectopic Pregnancy
|
Phase 3 | |
Enrolling by invitation |
NCT03579550 -
Hysteroscopic Metroplasty in Unexplained Infertile Women With Dysmorphic Uterus
|
N/A | |
Completed |
NCT05446012 -
Relationship Between Ectopic Pregnancy and Thyroid Disorders
|
||
Completed |
NCT00194168 -
Ectopic Pregnancy Biomarkers
|
N/A | |
Completed |
NCT02152696 -
Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location
|
Phase 3 | |
Not yet recruiting |
NCT04975984 -
Expectant Management of Ectopic Pregnancy
|